The BRCA2 mutation status shapes the immune phenotype of prostate cancer - Jenzer, Maximilian; Keß, Peter; Nientiedt, Cathleen; Endris, Volker; Kippenberger, Maximilian; Leichsenring, Jonas; Stögbauer, Fabian; Haimes, Josh; Mishkin, Skyler; Kudlow, Brian; Kaczorowski, Adam; Zschäbitz, Stefanie; et al. (Cancer immunology immunotherapy, 2019)
Gesehen am 04.02.2020